Financhill
Buy
62

MPLN Quote, Financials, Valuation and Earnings

Last price:
$12.10
Seasonality move :
-24.1%
Day range:
$6.40 - $13.39
52-week range:
$4.80 - $69.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.21x
P/B ratio:
0.95x
Volume:
2.1M
Avg. volume:
150.3K
1-year change:
-82%
Market cap:
$197.9M
Revenue:
$961.5M
EPS (TTM):
-$94.90

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MPLN
MultiPlan
$233M -$2.37 -3.84% -25.95% $10.00
DRIO
DarioHealth
$7.4M -$0.18 104.95% -60.98% --
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$2.6M -- -13% -- --
SPOK
Spok Holdings
$34.3M $0.24 4.56% 18.18% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MPLN
MultiPlan
$12.24 $10.00 $197.9M -- $0.00 0% 0.21x
DRIO
DarioHealth
$0.70 -- $23.9M -- $0.00 0% 1.09x
FOXO
FOXO Technologies
$0.25 -- $4.3M -- $0.00 0% 1.85x
OTRK
Ontrak
$1.45 -- $6.1M -- $0.00 0% 0.50x
SPOK
Spok Holdings
$15.96 -- $323.5M 21.86x $0.31 7.83% 2.37x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MPLN
MultiPlan
95.61% 0.073 3661.33% 0.91x
DRIO
DarioHealth
33.03% 1.132 82.25% 1.27x
FOXO
FOXO Technologies
224.55% 16.543 1241.69% 0.06x
OTRK
Ontrak
40.88% 4.227 95.85% 0.98x
SPOK
Spok Holdings
-- 0.265 -- 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MPLN
MultiPlan
$169.7M $23.4M -27.36% -141.48% -146.15% $41.1M
DRIO
DarioHealth
$3.9M -$12M -49.97% -71.65% -162.06% -$7.4M
FOXO
FOXO Technologies
$655K -$1.1M -- -- -83.28% $576K
OTRK
Ontrak
$1.6M -$5.1M -149.3% -231.34% -198.72% -$1.4M
SPOK
Spok Holdings
$27.7M $5.3M 9.13% 9.13% 15.31% $10.3M

MultiPlan vs. Competitors

  • Which has Higher Returns MPLN or DRIO?

    DarioHealth has a net margin of -169.83% compared to MultiPlan's net margin of -166.11%. MultiPlan's return on equity of -141.48% beat DarioHealth's return on equity of -71.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    DRIO
    DarioHealth
    52.23% -$0.25 $87.4M
  • What do Analysts Say About MPLN or DRIO?

    MultiPlan has a consensus price target of $10.00, signalling downside risk potential of -18.3%. On the other hand DarioHealth has an analysts' consensus of -- which suggests that it could grow by 400.07%. Given that DarioHealth has higher upside potential than MultiPlan, analysts believe DarioHealth is more attractive than MultiPlan.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 2 0
    DRIO
    DarioHealth
    3 0 0
  • Is MPLN or DRIO More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.468, suggesting its more volatile than the S&P 500 by 46.822%.

  • Which is a Better Dividend Stock MPLN or DRIO?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MultiPlan pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or DRIO?

    MultiPlan quarterly revenues are $230.5M, which are larger than DarioHealth quarterly revenues of $7.4M. MultiPlan's net income of -$391.5M is lower than DarioHealth's net income of -$12.3M. Notably, MultiPlan's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.21x versus 1.09x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.21x -- $230.5M -$391.5M
    DRIO
    DarioHealth
    1.09x -- $7.4M -$12.3M
  • Which has Higher Returns MPLN or FOXO?

    FOXO Technologies has a net margin of -169.83% compared to MultiPlan's net margin of -162.71%. MultiPlan's return on equity of -141.48% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    FOXO
    FOXO Technologies
    54.77% -$0.15 $14M
  • What do Analysts Say About MPLN or FOXO?

    MultiPlan has a consensus price target of $10.00, signalling downside risk potential of -18.3%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that MultiPlan has higher upside potential than FOXO Technologies, analysts believe MultiPlan is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 2 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is MPLN or FOXO More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock MPLN or FOXO?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MultiPlan pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or FOXO?

    MultiPlan quarterly revenues are $230.5M, which are larger than FOXO Technologies quarterly revenues of $1.2M. MultiPlan's net income of -$391.5M is lower than FOXO Technologies's net income of -$1.9M. Notably, MultiPlan's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.21x versus 1.85x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.21x -- $230.5M -$391.5M
    FOXO
    FOXO Technologies
    1.85x -- $1.2M -$1.9M
  • Which has Higher Returns MPLN or OTRK?

    Ontrak has a net margin of -169.83% compared to MultiPlan's net margin of -217.21%. MultiPlan's return on equity of -141.48% beat Ontrak's return on equity of -231.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    OTRK
    Ontrak
    62.05% -$1.77 $19.4M
  • What do Analysts Say About MPLN or OTRK?

    MultiPlan has a consensus price target of $10.00, signalling downside risk potential of -18.3%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 175.86%. Given that Ontrak has higher upside potential than MultiPlan, analysts believe Ontrak is more attractive than MultiPlan.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 2 0
    OTRK
    Ontrak
    0 0 0
  • Is MPLN or OTRK More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.569, suggesting its more volatile than the S&P 500 by 156.857%.

  • Which is a Better Dividend Stock MPLN or OTRK?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MultiPlan pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or OTRK?

    MultiPlan quarterly revenues are $230.5M, which are larger than Ontrak quarterly revenues of $2.6M. MultiPlan's net income of -$391.5M is lower than Ontrak's net income of -$5.6M. Notably, MultiPlan's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.21x versus 0.50x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.21x -- $230.5M -$391.5M
    OTRK
    Ontrak
    0.50x -- $2.6M -$5.6M
  • Which has Higher Returns MPLN or SPOK?

    Spok Holdings has a net margin of -169.83% compared to MultiPlan's net margin of 10.5%. MultiPlan's return on equity of -141.48% beat Spok Holdings's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    SPOK
    Spok Holdings
    79.54% $0.18 $156.3M
  • What do Analysts Say About MPLN or SPOK?

    MultiPlan has a consensus price target of $10.00, signalling downside risk potential of -18.3%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -6.02%. Given that MultiPlan has more downside risk than Spok Holdings, analysts believe Spok Holdings is more attractive than MultiPlan.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 2 0
    SPOK
    Spok Holdings
    0 0 0
  • Is MPLN or SPOK More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.334, suggesting its less volatile than the S&P 500 by 66.63%.

  • Which is a Better Dividend Stock MPLN or SPOK?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.83% to investors and pays a quarterly dividend of $0.31 per share. MultiPlan pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or SPOK?

    MultiPlan quarterly revenues are $230.5M, which are larger than Spok Holdings quarterly revenues of $34.9M. MultiPlan's net income of -$391.5M is lower than Spok Holdings's net income of $3.7M. Notably, MultiPlan's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 21.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.21x versus 2.37x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.21x -- $230.5M -$391.5M
    SPOK
    Spok Holdings
    2.37x 21.86x $34.9M $3.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock